Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma. [electronic resource]
Producer: 20130111Description: 1673-9 p. digitalISSN:- 1460-2105
- Animals
- Antineoplastic Agents -- pharmacology
- Aspartic Acid
- Benzamides -- pharmacology
- Blotting, Western
- Cell Line, Tumor
- Cyclin-Dependent Kinase Inhibitor p18 -- antagonists & inhibitors
- Cyclin-Dependent Kinase Inhibitor p21 -- antagonists & inhibitors
- Flow Cytometry
- Gene Expression Regulation, Neoplastic
- Genes, ras
- Glutamic Acid
- Glycine
- Humans
- MAP Kinase Signaling System -- drug effects
- Melanocytes -- metabolism
- Melanoma -- drug therapy
- Mice
- Mice, Nude
- Mitogen-Activated Protein Kinases -- metabolism
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Proto-Oncogene Proteins c-jun -- metabolism
- RNA, Small Interfering
- Transcription Factor AP-1 -- metabolism
- Transfection
- Transplantation, Heterologous
- Valine
- Viral Vaccines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.